1. Home
  2. PRME vs NKX Comparison

PRME vs NKX Comparison

Compare PRME & NKX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$2.84

Market Cap

666.1M

Sector

Health Care

ML Signal

HOLD

Logo Nuveen California AMT-Free Quality Municipal Income Fund

NKX

Nuveen California AMT-Free Quality Municipal Income Fund

HOLD

Current Price

$12.41

Market Cap

647.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRME
NKX
Founded
2019
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
666.1M
647.9M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
PRME
NKX
Price
$2.84
$12.41
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$7.56
N/A
AVG Volume (30 Days)
2.2M
143.9K
Earning Date
05-08-2026
01-01-0001
Dividend Yield
N/A
4.37%
EPS Growth
18.18
N/A
EPS
N/A
N/A
Revenue
$4,632,000.00
N/A
Revenue This Year
$7.06
N/A
Revenue Next Year
$47.01
N/A
P/E Ratio
N/A
N/A
Revenue Growth
55.28
N/A
52 Week Low
$1.11
$11.45
52 Week High
$6.94
$13.20

Technical Indicators

Market Signals
Indicator
PRME
NKX
Relative Strength Index (RSI) 33.53 51.65
Support Level N/A $12.40
Resistance Level $3.97 $12.54
Average True Range (ATR) 0.24 0.10
MACD -0.06 -0.01
Stochastic Oscillator 16.94 37.78

Price Performance

Historical Comparison
PRME
NKX

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About NKX Nuveen California AMT-Free Quality Municipal Income Fund

Nuveen California AMT-Free Quality Municipal Income Fund is a closed-end fixed income mutual fund. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Arizona individual income taxes and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. It invests across sectors such as healthcare, utilities, transportation, and housing.

Share on Social Networks: